tirzepatide cause diarrhea What are the causes of (Mounjaro)-induced diarrhea? can tirzepatide cause diarrhea and

Wegovy pill: first oral GLP-1 approved for weight loss In a landmark development, the FDA approved the Wegovy pill (oral semaglutide 25 mg) on December 22, 2025 , making it the worlds first oral GLP-1 receptor agonist approved specifically for weight management a major shift from the injection-only landscape [8]

Similarly, Bayoumy et al

Semaglutide also boosts insulin secretion at mealtime so the body can use glucose more efficiently

Electronic databases including PubMed, Embase, and Web of Science were searched from inception until August 2025 using keywords such as GLP-1 receptor agonist, diabetic retinopathy, glaucoma, age-related macular degeneration, ocular disease, and neuroprotection. The search focused on identifying preclinical studies, large-scale retrospective cohort studies, and post-hoc analyses of major clinical trials that evaluated the utility and potential mechanisms of GLP-1RAs in ophthalmic diseases

This approach aligns well with the appetite-suppressing effects of GLP-1 medications, which naturally reduce hunger and promote earlier satiety

In these trials, participants were randomly assigned to receive either oral semaglutide or placebo, alongside lifestyle interventions such as diet and exercise guidance